Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $40.5600 (0.62%) ($40.2700 - $40.6400) on Fri. Mar. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.6% (three month average) | RSI | 58 | Latest Price | $40.5600(0.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.7% a day on average for past five trading days. | Weekly Trend | BAX advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) SPLV(28%) XLV(28%) XLU(27%) IWD(24%) XLRE(24%) | Factors Impacting BAX price | BAX will decline at least -1.3% in a week (0% probabilities). VXX(-21%) GLD(-18%) KWEB(-14%) MCHI(-13%) FXI(-13%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.3% (StdDev 2.6%) | Hourly BBV | 0.2 () | Intraday Trend | 0.2% | | | |
|
5 Day Moving Average | $40.27(0.72%) | 10 Day Moving Average | $39.61(2.4%) | 20 Day Moving Average | $39.19(3.5%) | To recent high | -22.8% | To recent low | 7.9% | Market Cap | $20.693b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |